1. News | 2020.10.11

    A sentinel for health monitoring #podcast

    For the 2020 Pasteurdon (the Institut Pasteur’s public fundraising campaign), listen to a podcast in French. Mathieu Vidard, presenter of "La Terre au carré" on France Inter (major French public radio channel and part of Radio France), discusses with two distinguished scientists from the Institut Pasteur: Christophe d’Enfert, scientific director and ...

  2. News | 2020.10.10

    The brain, this great unknown #podcast

    Neurology is an interdisciplinary field, in which research has evolved significantly in recent decades. At the Institut Pasteur, research is conducted on many subjects related to the brain such as degenerative diseases, memory, brain connectivity or sensory deficits. For the 2020 Pasteurdon (the Institut Pasteur’s public fundraising campaign), a podcast in French has been recorded. Two '...

  3. Document de presse | 2022.10.21

    SpikImm announces the clinical trials start for SPK001, its monoclonal antibody against SARS-CoV-2

    SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by the Institut Pasteur's Human Immunology Laboratory, directed by Dr. Hugo Mouquet (Inserm Joint Research Unit), has been tested on three initial cohorts of healthy volunteers, and has demonstrated excellent tolerance, in the context of the...

  4. Événement | 2022.12.07

    Colloquium "Epidemics, pandemics: a never-ending story?"

    On the occasion of the bicentenary of the birth of Louis Pasteur, the Institut Pasteur is organizing a major conference day, open to everyone, on December 7 from 9 a.m., in the auditorium of the Centre d'information scientifique.Program and registration (in French)The goal of this conference is to analyze the major epidemics that have struck humanity since its origin and to draw lessons to...

  5. News | 2021.05.03

    New Edition of the Emerging & Re-emerging Viruses MOOC

    Free et Self-pacedEmerging and re-emerging viruses are key players among the different pathogens that have caused recent epidemics, as attested by several severe outbreaks affecting humans such as Ebola, chikungunya, influenza, Zika, dengue, SARS and MERS or outbreaks attacking animals such as rabies and bluetongue disease.This MOOC aims to provide a fundamental knowledge about the different...

  6. News | 2022.07.01

    Monitoring and early warning: Pasteur Center in Cameroon plays an active role in the response to SARS-CoV-2 virus

    As a first-line laboratory in the event of a health emergency, the Pasteur Center in Cameroon was naturally designated as a COVID-19 reference laboratory by the Cameroon health authorities in 2020. How did the Pasteur Center in Cameroon organize its response to this emerging novel virus at national level throughout the epidemic, and how is it monitoring the virus today?At the beginning of the...

  7. News | 2020.04.28

    International Network of Pasteur Institutes: deepening the scientific collective strategy

    Three years ago, the scientific community of the Institut Pasteur International Network  (IPIN) expressed its desire to build a comprehensive strategy in order to strengthen its positioning and establish itself as a global public health authority. The Scientific Steering Committee of the Institut Pasteur International Network(COS-RIIP) was created in August 2019 to help achieve this goal....

  8. Document de presse | 2024.02.22

    New epidemiological surveillance indicators for more effective monitoring of suicide attempts

    Teams from the Child and Adolescent Psychiatry Department at Robert Debré Hospital (AP-HP), the AP-HP Digital Services Department and the Institut Pasteur, coordinated by Romain Bey and Prof. Richard Delorme, have developed novel digital tools to improve mental health monitoring for people living in the Greater Paris region. The data in this retrospective study were generated by analyzing several...

  9. Document de presse | 2024.05.28

    AFROSCREEN: a key network for genomic surveillance in Sub-Saharan Africa

    Three years after its launch, AFROSCREEN meets all its objectives, developing effective genomic surveillance to tackle epidemics  in sub-Saharan Africa The AFROSCREEN project, financed to the tune of €10 million by Agence Française de Développement (AFD), has been working since 2021 to set up or strengthen sequencing platforms and build an operational network for monitoring emerging...

  10. Document de presse | 2023.08.09

    SARS-CoV-2: how the history of human populations influences their immune response

    During the COVID-19 pandemic, the clinical spectrum observed among people infected with SARS-CoV-2 ranged from asymptomatic carriage to death. Researchers at the Institut Pasteur, the CNRS and the Collège de France, in collaboration with researchers around the world1 , have investigated the extent and drivers of differences in immune responses to SARS-CoV-2 across populations from Central Africa...

Pages

Back to top